Vontobel Holding Ltd. Vertex Pharmaceuticals Inc Transaction History

Vontobel Holding Ltd.

$29.2 Billion
Q3 2024

A detailed history of Vontobel Holding Ltd. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Vontobel Holding Ltd. holds 113,296 shares of VRTX stock, worth $51 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

113,296

Previous 158,830 28.67%

Holding current value

$51 Million

Previous $74.4 Million 29.22%

% of portfolio

0.18%

Previous 0.25%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$460.0 - $505.78 $20.9 Million - $23 Million	-45,534 Reduced 28.67%	113,296 $52.7 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $19.8 Million - $24.5 Million	50,450 Added 46.55%	158,830 $74.4 Million
Q1 2024 May 10, 2024	BUY	$407.69 - $446.08 $6.43 Million - $7.04 Million	15,774 Added 17.03%	108,380 $45.3 Million
Q4 2023 Jun 03, 2024	SELL	$343.0 - $410.68 $2.13 Million - $2.55 Million	-6,200 Reduced 9.17%	61,434 $25 Million
Q4 2023 Jan 29, 2024	SELL	$343.0 - $410.68 $2.66 Million - $3.19 Million	-7,767 Reduced 7.74%	92,606 $37.7 Million
Q3 2023 Jun 03, 2024	SELL	$338.18 - $362.46 $122,759 - $131,572	-363 Reduced 0.53%	67,634 $23.5 Million
Q3 2023 Oct 10, 2023	SELL	$338.18 - $362.46 $127,832 - $137,009	-378 Reduced 0.38%	100,373 $34.9 Million
Q2 2023 Jun 03, 2024	BUY	$314.42 - $351.91 $3.27 Million - $3.66 Million	10,387 Added 18.03%	67,997 $23.9 Million
Q2 2023 Jul 24, 2023	BUY	$314.42 - $351.91 $7.49 Million - $8.38 Million	23,819 Added 30.96%	100,751 $35.5 Million
Q1 2023 Jun 03, 2024	SELL	$283.23 - $323.1 $14.4 Million - $16.4 Million	-50,770 Reduced 46.84%	57,610 $18.2 Million
Q1 2023 Apr 12, 2023	BUY	$283.23 - $323.1 $4.03 Million - $4.6 Million	14,233 Added 22.7%	76,932 $24.2 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $1.02 Million - $1.15 Million	3,573 Added 6.04%	62,699 $18.1 Million
Q3 2022 Nov 04, 2022	SELL	$273.83 - $305.53 $3.74 Million - $4.17 Million	-13,662 Reduced 18.77%	59,126 $17.3 Million
Q2 2022 Jul 27, 2022	SELL	$234.96 - $292.55 $4.21 Million - $5.24 Million	-17,903 Reduced 19.74%	72,788 $20.4 Million
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $5.76 Million - $6.79 Million	-26,006 Reduced 22.29%	90,691 $23.3 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $3.35 Million - $4.24 Million	18,953 Added 19.39%	116,697 $26 Million
Q3 2021 Oct 29, 2021	BUY	$181.39 - $202.99 $3.5 Million - $3.92 Million	19,318 Added 24.63%	97,744 $17.7 Million
Q2 2021 Aug 06, 2021	BUY	$187.49 - $221.1 $2.21 Million - $2.61 Million	11,786 Added 17.69%	78,426 $15.4 Million
Q1 2021 May 11, 2021	BUY	$207.02 - $241.31 $1.77 Million - $2.07 Million	8,572 Added 14.76%	66,640 $14.3 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $12 Million - $16 Million	58,068 New	58,068 $12.4 Million

Others Institutions Holding VRTX

# of Institutions

1,721

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Account

Vontobel Holding Ltd. Vertex Pharmaceuticals Inc Transaction History